Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa

Fatty liver disease is one of the most common liver diseases in the Middle East and North Africa region, and globally. Unfortunately, there is a lack of awareness regarding this condition. The nomenclature changes for NAFLD (to MAFLD or MASLD) have gained considerable attention in the hepatology community. Here, we present our point of view on this ongoing change and debate.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335–1347 (2023).

    Article  PubMed  Google Scholar 

  2. Lazarus, J. V. et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat. Rev. Gastroenterol. Hepatol. 19, 60–78 (2022).

    Article  CAS  PubMed  Google Scholar 

  3. Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73, 202–209 (2020).

    Article  PubMed  Google Scholar 

  4. Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29, 101133 (2024).

    Article  PubMed  Google Scholar 

  5. Shiha, G. et al. MAFLD 2022: an ELPA/ALPA/EASO-ECPO joint statement on disease stigma. J. Hepatol. 77, 1717–1719 (2022).

    Article  PubMed  Google Scholar 

  6. Younossi, Z. M. et al. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. J. Hepatol. 80, 419–430 (2024).

    Article  PubMed  Google Scholar 

  7. Méndez-Sánchez, N., Pal, S. C., Fassio, E., Díaz-Ferrer, J. & Prado-Robles, J. A. MAFLD: perceived stigma — a single-center Mexican patient survey. Hepatol. Int. 17, 507–508 (2023).

    Article  PubMed  Google Scholar 

  8. Fouad, Y., Sanai, F., Alboraie, M. & Zheng, M.-H. What the new definition of MASLD left behind: dual etiology with viral hepatitis. Clin. Gastroenterol. Hepatol. (2023).

    Article  PubMed  Google Scholar 

  9. Younossi, Z. M. et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J. Hepatol. (2024).

    Article  PubMed  Google Scholar 

  10. Fouad, Y. et al. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition. J. Hepatol. (2024).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Yasser Fouad.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fouad, Y., Barakat, S., Hashim, A. et al. Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa. Nat Rev Gastroenterol Hepatol 21, 297–298 (2024).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing